Volumes of the hippocampus and amygdala in patients with borderline personality disorder: A meta-analysis

Journal of Personality Disorders

Volumn 23, Issue 4, 2009, Pages 333-345

  Nunes, Paulo Menezes ^a   Wenzel, Amy ^b   Borges, Karinne Tavares ^a   Porto, Cristianne Ribeiro ^c   Caminha, Renato Maiato ^d   De Oliveira, Irismar Reis ^a  

^a FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c FEDERAL UNIVERSITY OF SERGIPE   (Brazil)

^d UNIVERSIDADE DO VALE DO RIO DOS SINOS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE; NEUROLEPTIC AGENT; PSYCHOTROPIC AGENT;

AMYGDALOID NUCLEUS; ARTICLE; BORDERLINE STATE; BRAIN ATROPHY; BRAIN SIZE; COMORBIDITY; HIPPOCAMPUS; HUMAN; LEFT HEMISPHERE; MEDICAL LITERATURE; RIGHT HEMISPHERE; SYSTEMATIC REVIEW;

AMYGDALA; BORDERLINE PERSONALITY DISORDER; CASE-CONTROL STUDIES; HIPPOCAMPUS; HUMANS; MAGNETIC RESONANCE IMAGING;

EID: 68949140726     PISSN: 0885579X     EISSN: 0885579X     Source Type: Journal    
DOI: 10.1521/pedi.2009.23.4.333     Document Type: Article

References (39)

1. Abramson, J. H. (2004). WINPEPI (PEPI-for-Windows): computer programs for epidemiologists. Epidemiologic Perspectives & Innovations, 1, 6 (available at http://www.brixtonhealth.com/pepi4windows.html).
2. Altshuler, L. L., Bartzokis, G., Grieder, T., Curran, J., & Mintz, J. (1998). Amygdala enlargement in bipolar disorder and hippocampal reduction in schizophrenia: An MRI study demonstrating neuroanatomic specificity. Archives of General Psychiatry, 55, 663-664.
3. American Psychiatric Association (1994). Diagnostic and Statistical Manual of Mental Diosrders, 4th ed. Washington, DC: American Psychiatric Association.
4. Borenstein, M., Hedges, L., Higgins, J., & Rothstein, H. (2008). Comprehensive Meta-Analysis, version 2.2.048, Retrieved November 7, 2008, at www.Meta-Analysis.com.
5. Brambilla, P., Soloff, P. H., Sala, M., Nicoletti, M. A., Keshavan, M. S., & Soares, J. C. (2004). Anatomical MRI study of borderline personality disorder patients. Psychiatric Research: Neuroimaging, 131, 125-133.
6. Bremner, J. D., Randall, P., Scott, T. M., Bronen, R. A., Seibyl, J. P., Southwick, S. M. et al. (1995). MRI-based measurement of hippocampal volume in patients with combat-related posttraumatic stress disorder. American Journal of Psychiatry, 152, 973-981.
7. Bremner, J. D., Randall, P., Vermetten, E., Staib, L., Bronen, R. A., Mazure, C. et al. (1997). Magnetic resonance imaging-based measurement of hippocampal volume in posttraumatic stress disorder related to childhood physical and sexual abuse - a preliminary report. Biological Psychiatry, 41, 23-32.
8. Coid, J., Yang, M., Tyrer, P., Roberts, A., & Ullrich, S. (2006). Prevalence and correlates of personality disorders in Great Britain. British Journal of Psychiatry, 188, 423-431.
9. Daniels, W. M., Richter, L., & Stein, D. J. (2004). The effects of repeated intra-amygdala CRF injections on rat behavior and HPA axis function after stress. Metabolic and Brain Disorders, 19, 15-23.
10. Driessen, M., Herrmann, J., Stahl, K., Zwaan, M., Meier, S., Hill, A. et al. (2000). Magnetic resonance imaging volumes of the hippocampus and the amygdala in women with borderline personality disorder and early traumatization. Archives of General Psychiatry, 57, 1115-1122.
11. Fanselow, M. S., & Gale, G. D. (2003). The amygdale, fear, and memory. Annals of the New York Academy of Sciences, 985, 125-134.
12. Frodl, T., Meisenzahl, E., Zetzsche, T., Bottlender, R., Born, C., Groll, C. et al. (2002). Enlargement of the amygdala volume in patients with a first episode of major depression. Biological Psychiatry, 51, 708-714.
13. Grant, B. F., Chou, S. P., Goldstein, R. B., Huang, B., Stinson, F. S., Saha, T. D. et al. (2008). Prevalence, correlates, disability, and comorbidity of DSM-IV borderline personality disorder: Results from the wave 2 National Epidemiologic Survey on Alcohol and Related Conditions. Journal of Clinical Psychiatry, 69, 533-545.
14. Gregg, T. R., & Siegel, A. (2001). Brain structures and neurotransmitters regulating aggression in cats: Implications for human aggression. Progress in Neuropsychopharmacology and Biological Psychiatry, 25, 91-140.
15. Gurvits, T. V., Shenton, M. E., Hokama, H., Ohta, H., Lasko, N. B., Gilbertson, M. W. et al. (1996). Magnetic resonance imaging study of hippocampal volume in chronic, combat-related posttraumatic stress disorder. Biological Psychiatry, 40, 1091-1099.
16. Haldane, M., & Frangou, S. (2004). New insights help define the pathophysiology of bipolar affective disorder: Neuroimaging and neuropathology findings. Progress in Neuropsychopharmacoly and Biological Psychiatry, 28, 943-960.
17. Hedges, L. V., & Olkin, I. (1985) Statistical Methods for Meta-Analysis. New York: Academic Press.
18. Irle, E., Lange, C., & Sachsse, U. (2005). Reduced size and abnormal asymmetry of parietal cortex in women with borderline personality disorder. Biological Psychiatry, 57, 173-182.
19. Lange, C., & Irle, E. (2004). Enlarged amygdala volume and reduced hippocampal volume in young women with major depression. Psychological Medicine, 34, 1059-1064.
20. Layden, M. A., Newman, C. F., Freeman, A., & Morse, S. B. (1993). Cognitive therapy of borderline personality disorder. Boston, Allyn & Bacon.
21. Lieb, K., Zanarini, M. C., Schmahl, C., Linehan, M. M., & Bohus, M. (2004). Borderline personality disorder. Lancet, 364, 453-461.
22. Miguel-Hidalgo, J. J., & Rajkowska, G. (2002). Morphological brain changes in depression: Can antidepressants reverse them? CNS Drugs, 16, 361-372.
23. McEwen, B. S., & Chattarji, S. (2004). Molecular mechanisms of neuroplasticity and pharmacological implications: The example of tianeptine. European Neuropsychopharmacology, 14, S497-S502.
24. Minzenberg, M. J., Fan, J., New, A. S., Tang, C. Y., & Siever, L. J. (2007). Frontolimbic structural changes in borderline personality disorder. Journal of Psychiatry Research, 42, 727-733.
25. New, A. S., Hazlett, E. A., Buchsbaum, M. S., Goodman, M., Mitelman, S. A., Newmark, R. et al. (2007). Amygdala-prefrontal disconnection in borderline personality disorder. Neuropsychopharmacology, 32, 1629-1640.
26. Pariante, C. M., & Miller, A. H. (2001). Glucocorticoid receptors in major depression: Relevance to pathophysiology and treatment. Biological Psychiatry, 49, 391-404.
27. Rusch, N., Tebartz van Elst, L., Ludaescher, P., Wilke, M., Huppertz, H. J., Thiel, T. et al. (2003). A voxel-based morphometric MRI study in female patients with borderline personality disorder. Neuroimage, 20, 385-392.
28. Samuels, J., Eaton, W. W., Bienvenu 3rd, O. J., Brown, C. H., Costa, P. T. Jr., & Nestadt, G. (2002). Prevalence and correlates of personality disorders in a community sample. British Journal of Psychiatry, 180, 536-542.
29. Schmahl, C. G., Vermetten, E., Elzinga, B. M., & Bremner, J. D. (2003). Magnetic resonance imaging of hippocampal and amygdala volume in women with childhood abuse and borderline personality disorder. Psychiatry Research: Neuroimaging, 122, 193-198.
30. Sidley, G. L., Whitaker, K., Calam, R., & Wells, A. (1997). The relationship between problem-solving and autobiographical memory in parasuicide patients. Behavioural and Cognitive Psychotherapy, 25, 195-202.
31. Squire, L. (1992). Memory and the hippocampus: A synthesis from findings with rats, monkeys, and humans. Psychological Review, 99, 195-231.
32. Stein, M. B., Koverola, C., Hanna, C., Torchia, M. G., & McClarty, B. (1997). Hippocampal volume in women victimized by childhood sexual abuse. Psychological Medicine, 27, 951-959.
33. Tebartz van Elst, L., Bäumer, D., Ebert, D., & Trimble, M. R. (2004). Chronic anti-dopaminergic medication might affect amygdala structure in patients with schizophrenia. Pharmacopsychiatry, 37, 217-220.
34. Tebartz van Elst, L., Woermann, F., Lemieux, L., & Trimble, M. R. (1999). Amygdala enlargement in dysthymia - a volumetric study of patients with temporal lobe epilepsy. Biological Psychiatry, 46, 1614-1623.
35. Tebartz van Elst, L., Hesslinger, B., Thiel, T., Geiger, E., Haegele, K., Lemieux, L. et al. (2003). Frontolimbic brain abnormalities in patients with borderline personality disorder: A volumetric magnetic resonance imaging study. Biological Psychiatry, 54, 163-171.
36. Torgersen, S., Kringlen, E., & Cramer, V. (2001). The prevalence of personality disorders in a community sample. Archives of General Psychiatry, 58, 590-596.
37. Trimble, M. R., & Tebartz van Elst, L. T. (2003). The amygdala and psychopathology studies in epilepsy. Annals of the New York Academy of Sciences, 985, 461-468.
38. Zetzsche, T., Frodl, T., Preuss, U. W., Schmitt, G., Seifert, D., Leinsinger, G. et al. (2006). Amygdala volume and depressive symptoms in patients with borderline personality disorder. Biological Psychiatry, 60, 302-310.
39. Zetzsche, T., Preuss, U. W., Frodl, T., Schmitt, G., Seifert, D., Münchhausen, E., et al. (2007). Hippocampal volume reduction and history of aggressive behaviour in patients with borderline personality disorder. Psychiatry Research: Neuroimaging, 154, 157-170.